Search Results - "MICHAEL, DAHM" :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial

by Geletneky, Karsten, Hajda, Jacek, Angelova, Assia L., Leuchs, Barbara, Capper, David, Bartsch, Andreas J., Neumann, Jan-Oliver, Schöning, Tilman, Hüsing, Johannes, Beelte, Birgit, Kiprianova, Irina, Roscher, Mandy, Bhat, Rauf, von Deimling, Andreas, Brück, Wolfgang, Just, Alexandra, Frehtman, Veronika, Löbhard, Stephanie, Terletskaia-Ladwig, Elena, Fry, Jeremy, Jochims, Karin, Daniel, Volker, Krebs, Ottheinz, Dahm, Michael, Huber, Bernard, Unterberg, Andreas, Rommelaere, Jean
Published in Molecular therapy (06.12.2017)

Get full text

Journal Article

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol

by Geletneky, Karsten, Huesing, Johannes, Rommelaere, Jean, Schlehofer, Joerg R, Leuchs, Barbara, Dahm, Michael, Krebs, Ottheinz, von Knebel Doeberitz, Magnus, Huber, Bernard, Hajda, Jacek
Published in BMC cancer (21.03.2012)

Get full text

Journal Article

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

A non-controlled, single arm, open label, phase II study of intravenous and intratumoral administration of ParvOryx in patients with metastatic, inoperable pancreatic cancer: ParvOryx02 protocol

by Hajda, Jacek, Lehmann, Monika, Krebs, Ottheinz, Kieser, Meinhard, Geletneky, Karsten, Jäger, Dirk, Dahm, Michael, Huber, Bernard, Schöning, Tilman, Sedlaczek, Oliver, Stenzinger, Albrecht, Halama, Niels, Daniel, Volker, Leuchs, Barbara, Angelova, Assia, Rommelaere, Jean, Engeland, Christine E, Springfeld, Christoph, Ungerechts, Guy
Published in BMC cancer (29.08.2017)

Get full text

Journal Article

Performance of T-Track® SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells

Performance of T-Track® SARS-CoV-2, an Innovative Dual Marker RT-qPCR-Based Whole-Blood Assay for the Detection of SARS-CoV-2-Reactive T Cells

by Kanis, Franziska M, Meier, Johannes P, Guldan, Harald, Niller, Hans-Helmut, Dahm, Michael, Dansard, Alexander, Zander, Thomas, Struck, Friedhelm, Soutschek, Erwin, Deml, Ludwig, Möbus, Selina, Barabas, Sascha
Published in Diagnostics (Basel) (22.08.2023)

Get full text

Journal Article

Detection of circulating tumor cells in blood using an optimized density gradient centrifugation

Detection of circulating tumor cells in blood using an optimized density gradient centrifugation

by Gertler, Ralf, Rosenberg, Robert, Fuehrer, Katrin, Dahm, Michael, Nekarda, Hjalmar, Siewert, Joerg Ruediger
Published in Recent results in cancer research (2003)

Get more information

Journal Article

Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

by Hajda, Jacek, Leuchs, Barbara, Angelova, Assia L, Frehtman, Veronika, Rommelaere, Jean, Mertens, Mieke, Pilz, Maximilian, Kieser, Meinhard, Krebs, Ottheinz, Dahm, Michael, Huber, Bernard, Engeland, Christine E, Mavratzas, Athanasios, Hohmann, Nicolas, Schreiber, Jutta, Jäger, Dirk, Halama, Niels, Sedlaczek, Oliver, Gaida, Matthias M, Daniel, Volker, Springfeld, Christoph, Ungerechts, Guy
Published in Clinical cancer research (15.10.2021)

Get full text

Journal Article

Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration

Differentiated NSC-34 motoneuron-like cells as experimental model for cholinergic neurodegeneration

by Maier, Oliver, Böhm, Julia, Dahm, Michael, Brück, Stefan, Beyer, Cordian, Johann, Sonja
Published in Neurochemistry international (01.06.2013)

Get full text

Journal Article

CANCER THERAPY WITH PARVOVIRUS COMBINED WITH BEVACIZUMAB

CANCER THERAPY WITH PARVOVIRUS COMBINED WITH BEVACIZUMAB

by WICK WOLFGANG, ANTJE WICK, KARSTEN GELETNEKY, JEAN ROMMELAERE, MICHAEL DAHM
Year of Publication 28.11.2019

Get full text

Patent

First combined intravenous and intracerebral application of an oncolytic virus, parvovirus h-1, in a phase I/IIa clinical trial in patients with recurrent glioblastoma multiforme (ParvOryx01)

First combined intravenous and intracerebral application of an oncolytic virus, parvovirus h-1, in a phase I/IIa clinical trial in patients with recurrent glioblastoma multiforme (ParvOryx01)

by Geletneky, Karsten, Huesing, Johannes, Dahm, Michael, Krebs, Ottheinz, Huber, Bernard, Capper, David, Rommelaere, Jean, Hajda, Jacek, Unterberg, Andreas
Published in Journal of clinical oncology (20.05.2014)

Get full text

Journal Article

Bioavailability, Biodistribution, and CNS Toxicity of Clinical-Grade Parvovirus H1 after Intravenous and Intracerebral Injection in Rats

Bioavailability, Biodistribution, and CNS Toxicity of Clinical-Grade Parvovirus H1 after Intravenous and Intracerebral Injection in Rats

by Geletneky, Karsten, Leoni, Anne-Laure, Pohlmeyer-Esch, Gabriele, Loebhard, Stephanie, Leuchs, Barbara, Hoefer, Constance, Jochims, Karin, Dahm, Michael, Huber, Bernard, Rommelaere, Jean, Krebs, Ottheinz, Hajda, Jacek
Published in Comparative medicine (01.02.2015)

Get full text

Journal Article

ET-21COMBINATION OF INTRAVENOUS AND INTRACEREBRAL INJECTION OF ONCOLYTIC PARVOVIRUS H-1 IN A PHASE I/IIA CLINICAL TRIAL OF PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME: PENETRATION OF H-1 VIRUS ACROSS THE BLOOD-BRAIN BARRIER

ET-21COMBINATION OF INTRAVENOUS AND INTRACEREBRAL INJECTION OF ONCOLYTIC PARVOVIRUS H-1 IN A PHASE I/IIA CLINICAL TRIAL OF PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME: PENETRATION OF H-1 VIRUS ACROSS THE BLOOD-BRAIN BARRIER

by Geletneky, Karsten, Angelova, Assia, Leuchs, Barbara, Bhat, Rauf, Just, Alexandra, Capper, David, Krebs, Ottheinz, Dahm, Michael, Huber, Bernard, Unterberg, Andreas, Hajda, Jacek, Rommelaere, Jean
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)

Get full text

Journal Article

Pathology, Organ Distribution, and Immune Response after Single and Repeated Intravenous Injection of Rats with Clinical-Grade Parvovirus H1

Pathology, Organ Distribution, and Immune Response after Single and Repeated Intravenous Injection of Rats with Clinical-Grade Parvovirus H1

by Geletneky, Karsten, Leoni, Anne-Laure, Pohlmeyer-Esch, Gabriele, Loebhard, Stephanie, Baetz, Andrea, Leuchs, Barbara, Roscher, Mandy, Hoefer, Constance, Jochims, Karin, Dahm, Michael, Huber, Bernard, Rommelaere, Jean, Krebs, Ottheinz, Hajda, Jacek
Published in Comparative medicine (01.02.2015)

Get full text

Journal Article

Establishment and validation of an ex vivo human cervical tissue model for local delivery studies

Establishment and validation of an ex vivo human cervical tissue model for local delivery studies

by Hiller, Christian, Bock, Udo, Balser, Sigrid, Haltner-Ukomadu, Eleonore, Dahm, Michael
Published in European journal of pharmaceutics and biopharmaceutics (01.02.2008)

Get full text

Journal Article

ET-21 COMBINATION OF INTRAVENOUS AND INTRACEREBRAL INJECTION OF ONCOLYTIC PARVOVIRUS H-1 IN A PHASE I/IIA CLINICAL TRIAL OF PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME: PENETRATION OF H-1 VIRUS ACROSS THE BLOOD-BRAIN BARRIER

ET-21 COMBINATION OF INTRAVENOUS AND INTRACEREBRAL INJECTION OF ONCOLYTIC PARVOVIRUS H-1 IN A PHASE I/IIA CLINICAL TRIAL OF PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME: PENETRATION OF H-1 VIRUS ACROSS THE BLOOD-BRAIN BARRIER

by Geletneky, K., Angelova, A., Leuchs, B., Bhat, R., Just, A., Capper, D., Krebs, O., Dahm, M., Huber, B., Unterberg, A., Hajda, J., Rommelaere, J.
Published in Neuro-oncology (Charlottesville, Va.) (01.11.2014)

Get full text

Journal Article

Correlation of CK‐20‐Positive Cells in Peripheral Venous Blood with Serum CEA Levels in Patients with Colorectal Carcinoma

Correlation of CK‐20‐Positive Cells in Peripheral Venous Blood with Serum CEA Levels in Patients with Colorectal Carcinoma

by Friederichs, Jan, Gertler, Ralf, Rosenberg, Robert, Dahm, Michael, Nekarda, Hjalmar, Holzmann, Bernhard, Siewert, Jörg Rüdiger
Published in World journal of surgery (01.12.2007)

Get full text

Journal Article

H-1 PV EXPRESSING RNAI EFFECTORS

H-1 PV EXPRESSING RNAI EFFECTORS

by Leuchs, Barbara, Dahm, Michael W, Li, Junwei
Year of Publication 19.10.2022

Get full text

Patent

H-1 PV EXPRESSING RNAi EFFECTORS

H-1 PV EXPRESSING RNAi EFFECTORS

by Leuchs, Barbara, Chen, Ying, Dahm, Michael W, Li, Junwei
Year of Publication 06.06.2024

Get full text

Patent

KRÆFTBEHANDLING MED EN PARVOVIRUS KOMBINERET MED BEVACIZUMAB

KRÆFTBEHANDLING MED EN PARVOVIRUS KOMBINERET MED BEVACIZUMAB

by WICK, Wolfgang, GELETNEKY, Karsten, ROMMELAERE, Jean, WICK, Antje, DAHM, Michael
Year of Publication 19.02.2024

Get full text

Patent

CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB

CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH BEVACIZUMAB

by WICK, Wolfgang, GELETNEKY, Karsten, ROMMELAERE, Jean, WICK, Antje, DAHM, Michael
Year of Publication 06.12.2023

Get full text

Patent

Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

by Leuchs, Barbara, Angelova, Assia, Dahm, Michael, Marchini, Antonio, Jager, Dirk, Rommelaere, Jean, Wick, Wolfgang
Year of Publication 23.04.2024

Get full text

Patent

1
2
3
4
5
6
7
8
9
10
11
Next
[11]